亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Second Generation Farnesyl Transferase Inhibitors

總結: Purdue University researchers have developed a strategy for intracellular delivery of the monophosphates of such FT inhibitors, which could provide an effective therapeutic approach.

技術優勢: Intracellular delivery of inhibitorsEnables absolute quantification of known compounds and relative quantification of unknown compounds in most cases using a single liquid chromatography-mass spectrometry (LC-MS) run

*Background: A type of mutated constitutively active protein, Ras, is seen in a significant number of cancers. There is a great deal of interest in preventing the Ras protein from localizing on cell membranes as an anticancer treatment. One way to prevent localization is to inhibit farnesyltransferase (FTase), the enzyme responsible for facilitating Ras attachment to the cell membrane. Traditional FTase inhibitors are highly charged and incapable of traversing the cell membrane to enter the cell.

*Web Links: Purdue Office of Technology CommercializationPurdueInnovation and EntrepreneurshipRichard BorchPurdue Medicinal Chemistry and Molecular Pharmacology

欲了解更多信息，請點擊這裡